VIKING GLOBAL INVESTORS LP
Position in DNA — Ginkgo Bioworks Holdings, Inc.
CIK 1103804
STAMFORD, CT
Position in DNA
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$35,449,338
+$13,521,544 QoQ
Shares Held
3,577,128
0.0% QoQ
Ownership
5.31%
of shares outstanding
% of Portfolio
0.10%
of 13F equity value
Holder Rank
#2
of 183 holders
Holding Since
Sep 2021
20 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in DNA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026VIKING GLOBAL INVESTORS LP holds $2,489,856,848 across 17 Biotechnology names. DNA ranks #12 (1.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | BBIO |
BridgeBio Pharma, Inc.
|
9,949,219 | $741,017,831 | |
| 2 | BMRN |
Biomarin Pharmaceutical Inc
|
7,616,563 | $435,819,734 | |
| 3 | ROIV |
Roivant Sciences Ltd.
|
6,271,467 | $221,947,217 | |
| 4 | MANE |
Veradermics, Inc
|
1,561,494 | $191,970,072 | |
| 5 | ORKA |
Oruka Therapeutics, Inc.
|
1,503,478 | $143,086,001 | |
| 6 | NAMS |
NewAmsterdam Pharma Co N.V.
|
4,203,567 | $142,458,885 | |
| 7 | SION |
Sionna Therapeutics, Inc.
|
3,195,181 | $140,556,012 | |
| 8 | PHVS |
Pharvaris N.V.
|
3,653,310 | $126,331,459 |
All Filings in DNA
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $35,449,338 | 3,577,128 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $21,927,794 | 3,577,128 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $29,725,933 | 3,577,128 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $52,154,526 | 3,577,128 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $40,242,690 | 3,577,128 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $20,389,629 | 3,577,128 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $35,127,396 | 3,577,128 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $29,153,593 | 3,577,128 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $47,790,432 | 143,085,126 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $165,978,746 | 143,085,126 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $241,813,862 | 143,085,126 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $258,984,078 | 143,085,126 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $266,138,334 | 143,085,126 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $190,303,217 | 143,085,126 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $106,613,862 | 63,085,126 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $317,722,473 | 101,834,126 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $64,460,219 | 27,084,126 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $205,752,230 | 51,055,144 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $2,817,548,246 | 339,055,144 | Shares | Sole | 2022-05-16 | |
| 2021-09-30 | $3,929,649,118 | 339,055,144 | Shares | Sole | 2022-05-16 | |
| No filing history on record for this holder in this stock. | ||||||